Ionis Pharmaceuticals
IONS
IONS
338 hedge funds and large institutions have $3.75B invested in Ionis Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 105 increasing their positions, 118 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $4.08B → $3.75B (-$332M)
11% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 118
43% less call options, than puts
Call options by funds: $14.9M | Put options by funds: $26.4M
Holders
338
Holding in Top 10
2
Calls
$14.9M
Puts
$26.4M
Top Buyers
| 1 | +$40.8M | |
| 2 | +$30.6M | |
| 3 | +$22.9M | |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$17.9M |
| 5 |
BlackRock
New York
|
+$12.8M |
Top Sellers
| 1 | -$44M | |
| 2 | -$43.5M | |
| 3 | -$40M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$34.9M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$33.8M |